Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Late annual account NBB
Fiscal year 2025 was filed 228 days after the legal deadline.
Financials
Financial year 2025
PHARMACIE CASTRIQUE from Comines-Warneton, company number BE0433926728, closed financial year 2025 with a result of € 39,081 after tax. For that financial year PHARMACIE CASTRIQUE recorded a gross margin of € 196,653 and equity of € 419,771. Compared with financial year 2024, the result moved from € 1,113 to € 39,081. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 15, 2026.
€ 419,771
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 39,081
▲ € 37,968 vs 2024
Profit after tax over the fiscal year.
€ 62,233
▼ 59% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 357,771.
People and assets in 2025
2.5
▲ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 138,111
▲ 4% vs 2024
€ 55,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 351,235
▼ 22% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 58,404
▲ 45% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 240,896 | € 168,020 | € 148,509 | € 196,653 | ▲ 32% |
| Profit after taxes | € 106,345 | € 6,663 | € 1,113 | € 39,081 | ▲ € 37,968 |
| Equity | € 372,914 | € 379,577 | € 380,690 | € 419,771 | ▲ 10% |
| Total debts | € 780,343 | € 463,473 | € 563,846 | € 509,110 | ▼ 10% |
| Cash | € 84,622 | € 34,238 | € 153,631 | € 62,233 | ▼ 59% |
| Land & buildings | € 38,443 | € 10,253 | € 0 | - | |
| Retained profit | € 310,914 | € 317,577 | € 318,690 | € 357,771 | ▲ 12% |
| Bank debt | € 160,818 | € 69,361 | € 20,085 | € 0 | ▼ 100% |
| Balance sheet total | € 1,153,257 | € 843,051 | € 944,536 | € 928,881 | ▼ 2% |
| Employees (FTE) | 1.1 | 2.1 | 2.2 | 2.5 | ▲ 0.3 |
Key figures of PHARMACIE CASTRIQUE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to PHARMACIE CASTRIQUE?
What happened at PHARMACIE CASTRIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Edward Vansteelant stepped down as director. NBB
- Jocelyne Leterme stepped down as director. NBB
- Pharmgeth NV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 39,081 (▲ € 37,968 vs 2024). filed late Source: NBB ↗
- Edward Vansteelant became a director. NBB
- Jocelyne Leterme became a director. NBB
- Pharmgeth NV became a director. NBB
- New establishment in Comines-Warneton. KBO
In short
From € 106,345 profit in 2022 to € 39,081 profit in 2025.
Paid € 36,507 in corporate taxes since 2022.
Best year ever: 2022, with € 106,345 profit.
On average € 78,700 of value added per employee in 2025.
A new publication or filing at PHARMACIE CASTRIQUE? We notify you, reason included.
Follow PHARMACIE CASTRIQUEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of PHARMGETH comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE CASTRIQUEThe shares are held by PHARMGETH (98.4%).
Directors
According to the 2025 annual accounts
Edward Vansteelant
Director
since 2024 · until 2030
since 2024 · until 2030
since 2024 · until 2030
Shareholders
98.4%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Ten-Brielenstraat(KOM) 77
7780 Comines-Warneton
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0433.926.728
- VAT number
- BE 0433.926.728
- Registered office
- Ten-Brielenstraat(KOM) 77, 7780 Comines-Warneton
- Names & denominations
- PHARMACIE CASTRIQUE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 March 1988
- Peppol
- Active · Active since 19 Nov 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten